Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2015-12-30 Board/Management Inform…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Board/Management Information 2015
Board/Management Information Classification · 100% confidence The document text, written in Danish, announces a change in senior management. Specifically, it states that Henning Borg has been appointed as the new CEO (administrerende direktør) and that the previous CEO, Staffan Mattson, is stepping down. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2015-12-30 Danish
Capital/Financing Update 2015
Capital/Financing Update Classification · 98% confidence The document details a new concrete acquisition strategy for the Russian real estate market, including specific financial criteria (minimum 15% return, 30% solvency), planned asset types (farmland, office buildings), and the required financing method (issuance of new shares, targeted private placement). It also includes a correction regarding a previous project (Portinho Hotel Project) that is now being divested. This content describes significant changes in the company's financing structure and investment focus, which strongly aligns with the definition of a Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend announcement (DIV). Since it details the need for DKK 60 million in equity financing via new share issuance, CAP is the most appropriate classification.
2015-11-12 Danish
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a formal announcement dated November 12, 2015, titled 'BLUE VISON A/S oplyser om fremtidige russiske projekter og korrektioner til tidligere meddelelser vedrørende Ejendomsprojektet Portinho' (BLUE VISION A/S announces future Russian projects and corrections to previous announcements regarding the Portinho Property Project). It details a new acquisition strategy (minimum 15% return, 30% solvency, local financing up to 70%), specific negotiations in Russia (Krasnodar region, Moscow office building), and the planned financing via a directed share issue ('rettet emission'). It also corrects previous information regarding a hotel project (Portinho) which is now being sold. This content—announcing strategic shifts, major investment plans requiring capital changes (share issuance), and significant asset divestitures—is characteristic of a material corporate event announcement. Since it is not a full annual report (10-K), a quarterly report (IR), an earnings release (ER), or a transcript (CT), and it specifically details management/board decisions regarding strategy and financing, it best fits the 'Capital/Financing Update' (CAP) category due to the explicit mention of raising DKK 60 million via new share issuance to fund the strategy, or potentially 'Regulatory Filings' (RNS) as a general announcement. Given the strong focus on financing (issuance of new shares) and strategic capital deployment, CAP is the most precise fit, although RNS is a possible fallback for non-standard regulatory disclosures in Danish.
2015-11-12 English
Capital/Financing Update 2015
Capital/Financing Update Classification · 95% confidence The document text, written in Danish, discusses the admission to trading and official listing of existing shares (10,111,392 shares) on NASDAQ Copenhagen following a resolution at the Annual General Meeting (AGM) on March 27, 2015. Specifically, it details the merger of A- and B-share classes into a single class and the subsequent listing of the former B-shares. It explicitly mentions the publication of a 'prospekt' (prospectus) in connection with this listing. Since the core action is related to a change in the capital structure (merging share classes and listing existing shares) and involves a formal document (prospectus) related to this capital event, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not a general share issue (SHA) as it involves listing already issued shares, nor is it a general AGM material (AGM-R) but a specific financial/capital action resulting from the AGM.
2015-03-27 Danish
Capital/Financing Update 2015
Capital/Financing Update Classification · 95% confidence The document is explicitly titled and structured as a "Prospekt" (Prospectus) in Danish. It details the admission to trading and official listing of existing shares on Nasdaq Copenhagen A/S. A prospectus is a formal legal document required to be published when securities are offered to the public or admitted to trading on a regulated market. This aligns perfectly with the definition of a document used for offering or listing securities, which is often associated with capital raising or listing activities. While it contains extensive financial and operational details (like a 10-K or IR), its primary function here is the formal listing disclosure, which is best categorized under Capital/Financing Update (CAP) or, given the context of a formal listing document, sometimes falls under a general offering/listing disclosure category. Since 'CAP' covers fundraising/financing activities and capital structure changes, and this document facilitates the listing/admission to trade of existing shares (a capital structure event), it is the most appropriate fit among the provided options, although 'RPA' or 'RNS' might be considered if it were merely an announcement *of* the prospectus. However, the text provided *is* the prospectus itself, detailing the transaction, risks, and structure, making it a core financing/listing document. Given the options, 'CAP' (Capital/Financing Update) is the closest fit for a document detailing the admission to trading of shares following capital structure decisions.
2015-03-27 English
AGM Information 2015
AGM Information Classification · 100% confidence The document text is a detailed protocol ('protokollat') written in Danish, detailing the proceedings and resolutions of a general meeting. Key agenda items include the Board's report, approval of the audited annual report ('revideret årsrapport'), distribution of profit/loss, proposals regarding share class consolidation and changes to the articles of association ('vedtægter'), and the election of the board and auditor. The content explicitly covers the formal decisions made at a general meeting, including voting results on management discharge and capital structure changes. This strongly indicates the document is the official minutes or record of an Annual General Meeting (AGM). The closest matching category is 'AGM Information' (AGM-R), which covers presentations and materials shared during the AGM. Although it contains elements of an Annual Report review (item 3), the primary function and format here is the record of the meeting itself.
2015-03-27 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.